| JYSB2000188 | AMG 199 | AMG 199 | Injection | Biological Products | Supplementary Application | 2020-05-15 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2020-05-19 | view |
| JXHL2000206 | AMG 510 | SOTORASIB | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2020-07-08 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-07-07 | view |
| JXHB2000033 | AMG 510 | SOTORASIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2020-09-25 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-09-24 | view |
| JXHB2100022 | AMG 510 | SOTORASIB | Active ingredient | Chemical Drugs(1) | Supplementary Application | 2021-02-21 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2021-02-20 | view |
| JXHL2000232 | AMG 650 | sovilnesib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2020-08-21 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-08-19 | view |
| JXHL2000231 | AMG 650 | sovilnesib | Active ingredient | Chemical Drugs(1) | Import Drug Application | 2020-08-21 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-08-19 | view |
| JYSB2000309 | AMG 701 | pavurutamab | Injection | Biological Products | Supplementary Application | 2020-06-29 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2020-06-30 | view |
| JXSL2000100 | AMG 910 | AMG 910 | Injection | Biological Products | Import Drug Application | 2020-07-01 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-06-29 | view |
| JXSB2000007 | AMG160 | acapatamab | Injection | Biological Products | Supplementary Application | 2020-08-21 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-08-19 | view |
| JXSL2000195 | AMG160 | acapatamab | Injection | Biological Products(1) | Import Drug Application | 2020-11-02 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-10-30 | view |
| JYSB2000219 | AMG160 | acapatamab | Injection | Biological Products | Supplementary Application | 2020-05-29 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Filed | 2020-06-04 | view |
| CXHL1301262 | BGB-283 | lifirafenib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301260 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301261 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1301259 | BGB-283胶囊 | lifirafenib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2014-05-20 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2015-07-27 | view |
| CXHL1501848 | BGB-290 | pamiparib | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHB2000046 | BGB-290 胶囊 | pamiparib | Capsule | Chemical Drugs | Supplementary Application | 2020-05-28 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-05-27 | view |
| CXHL1501849 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHL1501852 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs(1.1) | New Drug Application | 2015-11-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | Certificate Issued | 2016-08-12 | view |
| CXHB2000023 | BGB-290胶囊 | pamiparib | Capsule | Chemical Drugs | Supplementary Application | 2020-04-04 | 百济神州（北京）生物科技有限公司 | BeiGene (Beijing) Co Ltd | In Review | 2020-04-03 | view |
